Published online January 4, 2006
PEDIATRICS Vol. 117 No. 1 January 2006, pp. 184-191 (doi:10.1542/peds.2004-2773)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stiehm, E. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Stiehm, E. R.
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Measles
Malaria
Leprosy
Human Immunodeficiency Virus...
Epstein-Barr Virus Infections...
Tuberculosis
Smallpox (Variola)
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

SPECIAL ARTICLE

Disease Versus Disease: How One Disease May Ameliorate Another

E. Richard Stiehm, MD

Department of Pediatrics, Mattel Children's Hospital at UCLA, Los Angeles, California

Systemic disease, either genetic or acquired, may prevent or decrease the severity of another disease. These observations have led to important therapeutic advances. The best-known examples are Edward Jenner's use in 1798 of cowpox to prevent smallpox and J.B. Haldane's 1942 observation that erythrocyte disorders such as thalassemia and sickle cell disease modify the severity of malaria. Patients with and carriers of cystic fibrosis may have genetic resistance to tuberculosis and/or secretory diarrhea. The beneficial effects of undernutrition have led to therapeutic diets for seizures, celiac disease, type 2 diabetes, and inflammatory bowel disease. Finasteride for prostatic hypertrophy was developed after the observation that patients with male pseudohermaphrodism resulting from 5-{alpha}-reductase mutations do not develop prostatic hypertrophy. Rh immunoglobulin for Rh hemolytic disease prevention followed the observation that ABO incompatibility prevented Rh sensitization. The natural immunosuppression of measles may cause remission of nephrosis, and that of leprosy prevents psoriasis. Patients with one form of agammaglobulinemia (X-linked) never get Epstein-Barr virus infection, and patients with another form (common variable) are seemingly cured by HIV infection. HIV/AIDS is prevented or modified by co-receptor mutations (notably the CCR{Delta}32 chemokine mutation), HIV-2, or GB virus C infection. Additional exploration of these genetic, infectious, and metabolic influences on disease severity may provide new therapeutic approaches to HIV and other diseases.


Key Words: HIV • vaccination • receptor deficiency • agammaglobulinemia • starvation

Abbreviations: CF—cystic fibrosis • CFTR—cystic fibrosis transmembrane conductance regulator • EBV—Epstein-Barr virus • XLA—X-linked agammaglobulinemia • CVID—common variable immunodeficiency • GBV-C—GB virus type C


Accepted Mar 30, 2005.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
ChestHome page
L. Mutesa, A. K. Azad, C. Verhaeghe, K. Segers, J.-F. Vanbellinghen, L. Ngendahayo, E. K. Rusingiza, P. R. Mutwa, S. Rulisa, L. Koulischer, et al.
Genetic Analysis of Rwandan Patients With Cystic Fibrosis-Like Symptoms: Identification of Novel Cystic Fibrosis Transmembrane Conductance Regulator and Epithelial Sodium Channel Gene Variants
Chest, May 1, 2009; 135(5): 1233 - 1242.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. L. Doyle, C. A. Jefferies, C. Feighery, and L. A. J. O'Neill
Signaling by Toll-like Receptors 8 and 9 Requires Bruton's Tyrosine Kinase
J. Biol. Chem., December 21, 2007; 282(51): 36953 - 36960.
[Abstract] [Full Text] [PDF]